Biomedix Incubator Financials
| BMDX Stock | ILS 20,400 600.00 2.86% |
Biomedix |
Understanding current and past Biomedix Incubator Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Biomedix Incubator's financial statements are interrelated, with each one affecting the others. For example, an increase in Biomedix Incubator's assets may result in an increase in income on the income statement.
Please note, the presentation of Biomedix Incubator's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Biomedix Incubator's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Biomedix Incubator's management manipulating its earnings.
Biomedix Incubator Stock Summary
Biomedix Incubator competes with Libra Insurance, Discount Investment, Adgar Investments, Rapac Communication, and Clal Insurance. Biomedix Incubator Ltd is a venture capital firm and accelerator specializing in start-up and incubation investments. Biomedix Incubator Ltd. was founded in 2000 and is based in Ramat Gan, Israel with an additional office in New York, New York. Biomedix Incubator is traded on Tel Aviv Stock Exchange in Israel.| Instrument | Israel Stock View All |
| Exchange | Tel Aviv Stock Exchange |
| Business Address | 43 Simon Thassi |
| Benchmark | Dow Jones Industrial |
| Website | www.biomedixincubator.com |
| Phone | 972 3 613 8484 |
| Currency | ILS - Israeli Shekel |
You should never invest in Biomedix Incubator without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Biomedix Stock, because this is throwing your money away. Analyzing the key information contained in Biomedix Incubator's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Biomedix Incubator Key Financial Ratios
Biomedix Incubator's financial ratios allow both analysts and investors to convert raw data from Biomedix Incubator's financial statements into concise, actionable information that can be used to evaluate the performance of Biomedix Incubator over time and compare it to other companies across industries.| Return On Equity | -21.76 | |||
| Return On Asset | -14.0 | |||
| Beta | 1.21 | |||
| Z Score | -26.8 |
Biomedix Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Biomedix Incubator's current stock value. Our valuation model uses many indicators to compare Biomedix Incubator value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biomedix Incubator competition to find correlations between indicators driving Biomedix Incubator's intrinsic value. More Info.Biomedix Incubator is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Biomedix Incubator by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Biomedix Incubator's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Biomedix Incubator Systematic Risk
Biomedix Incubator's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Biomedix Incubator volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Biomedix Incubator correlated with the market. If Beta is less than 0 Biomedix Incubator generally moves in the opposite direction as compared to the market. If Biomedix Incubator Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Biomedix Incubator is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Biomedix Incubator is generally in the same direction as the market. If Beta > 1 Biomedix Incubator moves generally in the same direction as, but more than the movement of the benchmark.
Biomedix Incubator February 27, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Biomedix Incubator help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Biomedix Incubator. We use our internally-developed statistical techniques to arrive at the intrinsic value of Biomedix Incubator based on widely used predictive technical indicators. In general, we focus on analyzing Biomedix Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Biomedix Incubator's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.34 | |||
| Information Ratio | 0.0648 | |||
| Maximum Drawdown | 11.44 | |||
| Value At Risk | (3.67) | |||
| Potential Upside | 4.04 |
Complementary Tools for Biomedix Stock analysis
When running Biomedix Incubator's price analysis, check to measure Biomedix Incubator's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomedix Incubator is operating at the current time. Most of Biomedix Incubator's value examination focuses on studying past and present price action to predict the probability of Biomedix Incubator's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomedix Incubator's price. Additionally, you may evaluate how the addition of Biomedix Incubator to your portfolios can decrease your overall portfolio volatility.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |